Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications
The DOI matches its Crossref record.
Abstract
The metabolic syndrome (MetS) encompasses a constellation of cardio-metabolic abnormalities associated with a high risk of developing type 2 diabetes and cardiovascular disease (CVD), the top killer in the ageing population. Recent studies have demonstrated multiple beneficial effects of moderate wine consumption in the protection against development of the MetS and its related medical complications. The association of moderate wine consumption with lower incidence of the MetS and atherosclerotic heart disease has been repeatedly documented in numerous epidemiological studies on diverse ethnic groups. In addition to the favorable effects of moderate ethanol intake on lipid profiles, polyphenols enriched in red wine possess multiple benefits on the MetS beyond alcohol through their anti-oxidant, anti-inflammatory, vascular-protective and insulin-sensitizing properties. Notable among these red wine polypheolic compounds is resveratrol, a phytoalexin that has recently attracted great attention due to its role in mimicking calorie restriction. This compound can act as a potent activator of the NAD(+)-dependent deacetylases sirtuins to expand the life span and to prevent the deleterious effects of excess intake on insulin resistance and metabolic derangement. In addition, resveratrol exerts its multiple protective effects against the MetS through stimulating AMP-activated protein kinase and promoting mitochondria biogenesis. In this review, we highlight the recent epidemiological and experimental evidences supporting the protective effects of moderate wine intake against the MetS and its associated cardio-metabolic complications, and discuss the molecular mechanisms underlying the multiple beneficial actions of red wine polyphenols with the focus on resveratrol.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Resveratrol alleviates alcoholic fatty liver in mice
Ajmo, J. M., Liang, X., Rogers, C. Q., Pennock, B., & You, M. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90358.2008 · Cited by 314
Alcaín, F. J., & Villalba, J. M. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902762893 · Cited by 137
“The association of moderate wine consumption with lower incidence of the metabolic syndrome and atherosclerotic heart disease has been repeatedly documented in numerous epidemiological studies on diverse ethnic groups, the beneficial effect being associated to the presence of RV in red wine [68].”
BackgroundAssociations Between Unhealthy Lifestyle Behaviors and Metabolic Syndrome by Gender in Young Adults
Lin, K.-M., Chiou, J.-Y., Kuo, H.-W., Tan, J.-Y., Ko, S.-H., & Lee, M.-C. (2019) · Biological Research For Nursing · doi:10.1177/1099800418816175 · Cited by 20
Metadata
- Authors
- Liu, L., Wang, Y., Lam, K., & Xu, A.
- Venue
- Endocrine‚ Metabolic & Immune Disorders-Drug Targets
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2008-06-01
- Volume
- 8
- Issue
- 2
- Pages
- 89-98
- ISSN
- 1871-5303 (ISSN-L)
- OpenAlex
- W2144669446
- Cited by
- 52
- References
- 0
- FWCI
- 2.28
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications. https://app.cochat.ai/papers/10.2174/187153008784534385
- The paper
- Liu, L., Wang, Y., Lam, K., & Xu, A. (2008). Moderate Wine Consumption in the Prevention of Metabolic Syndrome and its Related Medical Complications. Endocrine‚ Metabolic & Immune Disorders-Drug Targets. https://doi.org/10.2174/187153008784534385
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.